Susceptibility-weighted imaging: technical essentials and clinical neurologic applications
Susceptibility-weighted imaging (SWI) evolved from simple two-dimensional T2*-weighted
sequences to three-dimensional sequences with improved spatial resolution and enhanced …
sequences to three-dimensional sequences with improved spatial resolution and enhanced …
Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease
JY Lee, A Martin-Bastida, A Murueta-Goyena… - Nature Reviews …, 2022 - nature.com
Parkinson disease (PD) is a progressive disorder characterized by dopaminergic
neurodegeneration in the brain. The development of parkinsonism is preceded by a long …
neurodegeneration in the brain. The development of parkinsonism is preceded by a long …
Neuroimaging in dementia: more than typical Alzheimer disease
Alzheimer disease (AD) is the most common cause of dementia. The prevailing theory of the
underlying pathology assumes amyloid accumulation followed by tau protein aggregation …
underlying pathology assumes amyloid accumulation followed by tau protein aggregation …
Imaging the substantia nigra in Parkinson disease and other Parkinsonian syndromes
Parkinson disease is characterized by dopaminergic cell loss in the substantia nigra of the
midbrain. There are various imaging markers for Parkinson disease. Recent advances in …
midbrain. There are various imaging markers for Parkinson disease. Recent advances in …
Magnetic resonance imaging for the diagnosis of Parkinson's disease
B Heim, F Krismer, R De Marzi, K Seppi - Journal of neural transmission, 2017 - Springer
The differential diagnosis of parkinsonian syndromes is considered one of the most
challenging in neurology and error rates in the clinical diagnosis can be high even at …
challenging in neurology and error rates in the clinical diagnosis can be high even at …
Prodromal Parkinson's disease: the decade past, the decade to come
RB Postuma, D Berg - Movement disorders, 2019 - Wiley Online Library
The past decade has seen a dramatic expansion of the field of prodromal PD. Ten years
ago, there were only six known prodromal markers of disease, none of which had more than …
ago, there were only six known prodromal markers of disease, none of which had more than …
Neuroimaging advances in Parkinson's disease and atypical Parkinsonian syndromes
U Saeed, AE Lang, M Masellis - Frontiers in neurology, 2020 - frontiersin.org
Parkinson's disease (PD) and atypical Parkinsonian syndromes are progressive
heterogeneous neurodegenerative diseases that share clinical characteristic of …
heterogeneous neurodegenerative diseases that share clinical characteristic of …
Alpha-synuclein as a biomarker of Parkinson's disease: good, but not good enough
Parkinson's disease (PD) is the second most common neurodegenerative disorder of the
elderly, presenting primarily with symptoms of motor impairment. The disease is diagnosed …
elderly, presenting primarily with symptoms of motor impairment. The disease is diagnosed …
Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts
U Saeed, J Compagnone, RI Aviv, AP Strafella… - Translational …, 2017 - Springer
Two centuries ago in 1817, James Parkinson provided the first medical description of
Parkinson's disease, later refined by Jean-Martin Charcot in the mid-to-late 19th century to …
Parkinson's disease, later refined by Jean-Martin Charcot in the mid-to-late 19th century to …
The concept of prodromal Parkinson's disease
P Mahlknecht, K Seppi… - Journal of Parkinson's …, 2015 - content.iospress.com
Parkinson's disease (PD) is currently clinically defined by a set of cardinal motor features
centred on the presence of bradykinesia and at least one additional motor symptom out of …
centred on the presence of bradykinesia and at least one additional motor symptom out of …